Hibi Toshifumi相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的中度活动性溃疡性结肠炎患者有效

期刊:Inflammatory Bowel Diseases

影响因子:4.3

doi:10.1093/ibd/izaf195

Yarur, Andres; Irving, Peter; Siegmund, Britta; Dubinsky, Marla C; Ananthakrishnan, Ashwin N; Regueiro, Miguel; Ungaro, Ryan C; Ritter, Timothy; Nakase, Hiroshi; Liu, Zhaohui; Mehra, Dimpy; Osterman, Mark T; Jain, Anjali; Rubin, David T; Hibi, Toshifumi

发表日期：2026

文献求助收藏

Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study

影响维多珠单抗治疗溃疡性结肠炎1年持续性的因素：一项多中心回顾性真实世界研究

期刊:Intestinal Research

影响因子:3.9

doi:10.5217/ir.2024.00063

Kobayashi, Taku; Hisamatsu, Tadakazu; Motoya, Satoshi; Fujii, Toshimitsu; Kunisaki, Reiko; Shibuya, Tomoyoshi; Matsuura, Minoru; Takeuchi, Ken; Hiraoka, Sakiko; Yasuda, Hiroshi; Yokoyama, Kaoru; Takatsu, Noritaka; Maemoto, Atsuo; Tahara, Toshiyuki; Tominaga, Keiichi; Shimada, Masaaki; Kuno, Nobuaki; Fernandez, Jovelle L; Ishiguro, Kaori; Cavaliere, Mary; Deguchi, Hisato; Hibi, Toshifumi

发表日期：2026

文献求助收藏

Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis

抗整合素αvβ6自身抗体可预测溃疡性结肠炎患者对高级疗法的反应和治疗持续性

期刊:Clinical and Translational Gastroenterology

doi:10.14309/ctg.0000000000000990

Shibui, Shunsuke; Asonuma, Kunio; Kuronuma, Satoshi; Okabayashi, Shinji; Nogami, Akira; Komatsu, Moeko; Serizawa, Kanade; Umeda, Satoko; Sagami, Shintaro; Berman, Galia; Takeuchi, Osamu; Nakano, Masaru; Hibi, Toshifumi; Maharshak, Nitsan; Maeda, Shin; Kobayashi, Taku

免疫/内分泌

发表日期：2026

文献求助收藏

Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study

filgotinib长期治疗日本溃疡性结肠炎患者的安全性和有效性：SELECTION长期扩展研究的中期亚组分析

期刊:Crohns Colitis 360

影响因子:2.6

doi:10.1093/crocol/otag006

Matsuoka, Katsuyoshi; Hata, Erina; Kaise, Toshihiko; Rudolph, Christine; Hibi, Toshifumi

发表日期：2026

文献求助收藏

Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study

mirikizumab 对克罗恩病患者报告结局和生活质量的影响：来自 SERENITY II 期研究的结果

期刊:Crohns Colitis 360

影响因子:2.6

doi:10.1093/crocol/otag018

Jairath, Vipul; Hunter Gibble, Theresa; Peyrin-Biroulet, Laurent; Sands, Bruce E; Hirai, Fumihito; Hibi, Toshifumi; Loftus, Edward V Jr; Cross, Raymond K; Protic, Marijana; Chan, Lai Shan; Morris, Nathan; Traxler, Kristina; Rubin, David T

发表日期：2026

文献求助收藏

Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study

每日一次口服奥扎尼莫德治疗日本溃疡性结肠炎患者：来自 J-True North 2/3 期研究的结果

期刊:Gastro Hep Advances

doi:10.1016/j.gastha.2025.100812

Nakase, Hiroshi; Fujii, Toshimitsu; Hisamatsu, Tadakazu; Suzuki, Yasuo; Watanabe, Mamoru; Takahashi, Sakuma; Ooi, Makoto; Takeuchi, Ken; Kimura, Tsuguhiro; Furuya, Ken; Aoyama, Nobuo; Hasatani, Kenkei; Horiki, Noriyuki; Kanke, Kazunari; Tokito, Satoki; Sai, Souken; Uchikawa, Yoko; Goto, Shoichiro; Fujimoto, Go; Zhang, Changliang; Petersen, AnnKatrin; Hibi, Toshifumi

发表日期：2026

文献求助收藏

Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)

优化卡罗替格司特甲酯在溃疡性结肠炎中的应用：患者特征分析、预测性生物标志物和疗效评估时机（ASPECT 研究）

期刊:Journal of Gastroenterology

影响因子:5.5

doi:10.1007/s00535-025-02299-9

Matsuoka, Katsuyoshi; Hirai, Fumihito; Watanabe, Kenji; Hokari, Ryota; Kobayashi, Taku; Saruta, Masayuki; Nakase, Hiroshi; Suzuki, Takahiro; Yamazaki, Gakuto; Hibi, Toshifumi; Watanabe, Mamoru; Hisamatsu, Tadakazu

发表日期：2025

文献求助收藏

Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study

在 2 期 AMAG 研究中，Mirikizumab 对中重度活动性克罗恩病患者的疲劳症状具有持续影响

期刊:Inflammatory Bowel Diseases

影响因子:4.3

doi:10.1093/ibd/izae166

Regueiro, Miguel; Fischer, Monika; Bossuyt, Peter; McGinnis, Kim; Protic, Marijana; Hunter Gibble, Theresa; Panni, Tommaso; Chan, Lai Shan; Hibi, Toshifumi; Rubin, David T

发表日期：2025

文献求助收藏

Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study

菲戈替尼治疗溃疡性结肠炎疗效的介质：在 SELECTION 2b/3 期研究中探索循环生物标志物

期刊:Inflammatory Bowel Diseases

影响因子:4.3

doi:10.1093/ibd/izae278

Nakase, Hiroshi; Danese, Silvio; Reinisch, Walter; Ritter, Timothy; Liang, Yan; Wendt, Emily; Levesque, Barrett G; Yoon, Oh Kyu; Tian, Yuan; Zhuo, Luting; Karouzakis, Emmanuel; Bauer, Yasmina; Oortwijn, Alessandra; Kaise, Toshihiko; Malkov, Vladislav A; Hibi, Toshifumi

发表日期：2025

文献求助收藏

Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn's Disease: Results from the Japanese CONFIDE Study

患者和医护人员对溃疡性结肠炎和克罗恩病负担及日常生活影响的看法：来自日本 CONFIDE 研究的结果

期刊:Advances in Therapy

doi:10.1007/s12325-024-03078-3

Hibi, Toshifumi; Kobayashi, Taku; Tanaka, Masaru; Osaga, Satoshi; Potts Bleakman, Alison J; Hunter Gibble, Theresa; Nedeljkovic Protic, Marijana; Redondo, Isabel; Matsuo, Koji; Hisamatsu, Tadakazu

发表日期：2025

文献求助收藏